Lonza Group AG (LZAGF)
OTCMKTS · Delayed Price · Currency is USD
690.12
-3.07 (-0.44%)
Jan 7, 2026, 3:52 PM EST
Lonza Group AG Market Cap
Lonza Group AG has a market cap or net worth of $47.44 billion as of January 7, 2026. Its market cap has increased by 6.44% in one year.
Market Cap
47.44B
Enterprise Value
52.17B
Revenue
8.92B
Ranking
n/a
PE Ratio
51.47
Stock Price
$690.12
Market Cap Chart
Since November 1, 1999, Lonza Group AG's market cap has increased from 3.78B to 47.44B, an increase of 1,155.21%. That is a compound annual growth rate of 10.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 48.43B | 1.37% |
| Dec 30, 2025 | 47.77B | 11.97% |
| Dec 30, 2024 | 42.67B | 36.74% |
| Dec 29, 2023 | 31.20B | -14.17% |
| Dec 30, 2022 | 36.35B | -41.26% |
| Dec 30, 2021 | 61.89B | 29.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 726.40M |
| Elite Pharmaceuticals | 516.25M |
| Northwest Biotherapeutics | 444.91M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 270.65M |